Haleon (LON:HLN) Announces Earnings Results

Haleon (LON:HLN) posted its earnings results on Friday. The company reported GBX 15.80 ($0.20) earnings per share for the quarter, Digital Look Earnings reports. Haleon had a net margin of 9.66% and a return on equity of 6.54%.

Haleon Stock Performance

HLN traded up GBX 12.90 ($0.16) during trading hours on Friday, hitting GBX 395.30 ($4.98). 76,461,156 shares of the stock were exchanged, compared to its average volume of 27,171,533. Haleon has a 12 month low of GBX 308.37 ($3.89) and a 12 month high of GBX 402.30 ($5.07). The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93. The stock has a 50-day simple moving average of GBX 379.73 and a 200-day simple moving average of GBX 379.15. The stock has a market cap of £35.68 billion, a price-to-earnings ratio of 33.25, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.